{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:41:04Z","timestamp":1791308464471,"version":"4.3.1"},"reference-count":112,"publisher":"Journal of Biomedical Research","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2022]]},"DOI":"10.7555\/jbr.36.20220123","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T21:04:26Z","timestamp":1660856666000},"page":"375","source":"Crossref","is-referenced-by-count":30,"title":["Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy"],"prefix":"10.7555","volume":"36","author":[{"given":"Natalia V.","family":"Naryzhnaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid N.","family":"Maslov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr V.","family":"Mukhomezyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav V.","family":"Ryabov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris K.","family":"Kurbatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Gombozhapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ming","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Logvinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"key-10.7555\/JBR.36.20220123-1","doi-asserted-by":"publisher","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al.  Heart disease and stroke statistics-2015 update: a report from the American Heart Association[J]. <i>Circulation, <\/i>2015, 131(4): e29\u2013e322.","DOI":"10.1161\/CIR.0000000000000152"},{"key":"key-10.7555\/JBR.36.20220123-2","doi-asserted-by":"publisher","unstructured":"Benjamin EJ, Virani SS, Callaway CW, et al.  Heart disease and stroke statistics-2018 update: a report from the American Heart Association[J]. <i>Circulation, <\/i>2018, 137(12): e67\u2013e492.","DOI":"10.1161\/CIR.0000000000000558"},{"key":"key-10.7555\/JBR.36.20220123-3","doi-asserted-by":"publisher","unstructured":"De Geest B, Mishra M.  Role of high-density lipoproteins in cardioprotection and in reverse remodeling: therapeutic implications[J]. <i>Biochim Biophys Acta Mol Cell Biol Lipids, <\/i>2021, 1866(11): 159022.","DOI":"10.1016\/j.bbalip.2021.159022"},{"key":"key-10.7555\/JBR.36.20220123-4","doi-asserted-by":"publisher","unstructured":"D'Elia N, D'hooge J, Marwick TH.  Association between myocardial mechanics and ischemic LV remodeling[J]. <i>JACC Cardiovasc Imaging, <\/i>2015, 8(12): 1430\u20131443.","DOI":"10.1016\/j.jcmg.2015.10.005"},{"key":"key-10.7555\/JBR.36.20220123-5","doi-asserted-by":"publisher","unstructured":"van der Bijl P, Abou R, Goedemans L, et al.  Left ventricular post-infarct remodeling: implications for systolic function improvement and outcomes in the modern Era[J]. <i>JACC Heart Fail, <\/i>2020, 8(2): 131\u2013140.","DOI":"10.1016\/j.jchf.2019.08.014"},{"key":"key-10.7555\/JBR.36.20220123-6","doi-asserted-by":"publisher","unstructured":"Yang C, Shen Y, Lu L, et al.  Insulin resistance and dysglycemia are associated with left ventricular remodeling after myocardial infarction in non-diabetic patients[J]. <i>Cardiovasc Diabetol, <\/i>2019, 18(1): 100.","DOI":"10.1186\/s12933-019-0904-3"},{"key":"key-10.7555\/JBR.36.20220123-7","doi-asserted-by":"publisher","unstructured":"Ryabov V, Gombozhapova A, Rogovskaya Y, et al.  Cardiac CD68<sup>+<\/sup> and stabilin-1<sup>+<\/sup> macrophages in wound healing following myocardial infarction: from experiment to clinic[J]. <i>Immunobiology, <\/i>2018, 223(4\u20135): 413\u2013421.","DOI":"10.1016\/j.imbio.2017.11.006"},{"key":"key-10.7555\/JBR.36.20220123-8","doi-asserted-by":"publisher","unstructured":"Weil BR, Neelamegham S.  Selectins and immune cells in acute myocardial infarction and post-infarction ventricular remodeling: pathophysiology and novel treatments[J]. <i>Front Immunol, <\/i>2019, 10: 300.","DOI":"10.3389\/fimmu.2019.00300"},{"key":"key-10.7555\/JBR.36.20220123-9","doi-asserted-by":"publisher","unstructured":"Toldo S, Mezzaroma E, van Tassell BW, et al.  Interleukin-1\u03b2 blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse[J]. <i>Exp Physiol, <\/i>2013, 98(3): 734\u2013745.","DOI":"10.1113\/expphysiol.2012.069831"},{"key":"key-10.7555\/JBR.36.20220123-10","doi-asserted-by":"publisher","unstructured":"Popov SV, Maslov LN, Naryzhnaya NV, et al.  The role of pyroptosis in ischemic and reperfusion injury of the heart[J]. <i>J Cardiovasc Pharmacol Ther, <\/i>2021, 26(6): 562\u2013574.","DOI":"10.1177\/10742484211027405"},{"key":"key-10.7555\/JBR.36.20220123-11","doi-asserted-by":"publisher","unstructured":"Swanson KV, Deng M, Ting JPY.  The NLRP3 inflammasome: molecular activation and regulation to therapeutics[J]. <i>Nat Rev Immunol, <\/i>2019, 19(8): 477\u2013489.","DOI":"10.1038\/s41577-019-0165-0"},{"key":"key-10.7555\/JBR.36.20220123-12","doi-asserted-by":"publisher","unstructured":"Martinon F, Burns K, Tschopp J.  A molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2[J]. <i>Mol Cell, <\/i>2002, 10(2): 417\u2013426.","DOI":"10.1016\/s1097-2765(02)00599-3"},{"key":"key-10.7555\/JBR.36.20220123-13","doi-asserted-by":"publisher","unstructured":"Poznyak AV, Melnichenko AA, Wetzker R, et al.  NLPR3 inflammasomes and their significance for atherosclerosis[J]. <i>Biomedicines, <\/i>2020, 8(7): 205.","DOI":"10.3390\/biomedicines8070205"},{"key":"key-10.7555\/JBR.36.20220123-14","doi-asserted-by":"publisher","unstructured":"Sebastian-Valverde M, Pasinetti GM.  The NLRP3 inflammasome as a critical actor in the inflammaging process[J]. <i>Cells, <\/i>2020, 9(6): 1552.","DOI":"10.3390\/cells9061552"},{"key":"key-10.7555\/JBR.36.20220123-15","doi-asserted-by":"publisher","unstructured":"Silvis MJM, Demkes EJ, Fiolet ATL, et al.  Immunomodulation of the NLRP3 inflammasome in atherosclerosis, coronary artery disease, and acute myocardial infarction[J]. <i>J Cardiovasc Trans Res, <\/i>2021, 14(1): 23\u201334.","DOI":"10.1007\/s12265-020-10049-w"},{"key":"key-10.7555\/JBR.36.20220123-16","doi-asserted-by":"publisher","unstructured":"Wang S, Zhu H, Li R, et al.  DNA-PKcs interacts with and phosphorylates Fis1 to induce mitochondrial fragmentation in tubular cells during acute kidney injury[J]. <i>Sci Signal, <\/i>2022, 15(725): eabh1121.","DOI":"10.1126\/scisignal.abh1121"},{"key":"key-10.7555\/JBR.36.20220123-17","doi-asserted-by":"publisher","unstructured":"He W, Wan H, Hu L, et al.  Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion[J]. <i>Cell Res, <\/i>2015, 25(12): 1285\u20131298.","DOI":"10.1038\/cr.2015.139"},{"key":"key-10.7555\/JBR.36.20220123-18","doi-asserted-by":"publisher","unstructured":"Shi J, Zhao Y, Wang K, et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. <i>Nature, <\/i>2015, 526(7575): 660\u2013665.","DOI":"10.1038\/nature15514"},{"key":"key-10.7555\/JBR.36.20220123-19","doi-asserted-by":"publisher","unstructured":"Wang Q, Wu J, Zeng Y, et al.  Pyroptosis: a pro-inflammatory type of cell death in cardiovascular disease[J]. <i>Clin Chim Acta, <\/i>2020, 510: 62\u201372.","DOI":"10.1016\/j.cca.2020.06.044"},{"key":"key-10.7555\/JBR.36.20220123-20","doi-asserted-by":"publisher","unstructured":"Mezzaroma E, Toldo S, Farkas D, et al.  The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse[J]. <i>Proc Natl Acad Sci U S A, <\/i>2011, 108(49): 19725\u201319730.","DOI":"10.1073\/pnas.1108586108"},{"key":"key-10.7555\/JBR.36.20220123-21","doi-asserted-by":"publisher","unstructured":"Liu A, Gao X, Zhang Q, et al.  Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway[J]. <i>Mol Med Rep, <\/i>2013, 8(2): 361\u2013366.","DOI":"10.3892\/mmr.2013.1507"},{"key":"key-10.7555\/JBR.36.20220123-22","doi-asserted-by":"publisher","unstructured":"Liu W, Zhang X, Zhao M, et al.  Activation in M1 but not M2 macrophages contributes to cardiac remodeling after myocardial infarction in rats: a critical role of the calcium sensing receptor\/NRLP3 inflammasome[J]. <i>Cell Physiol Biochem, <\/i>2015, 35(6): 2483\u20132500.","DOI":"10.1159\/000374048"},{"key":"key-10.7555\/JBR.36.20220123-23","doi-asserted-by":"publisher","unstructured":"Sano S, Oshima K, Wang Y, et al.  Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome[J]. <i>J Am Coll Cardiol, <\/i>2018, 71(8): 875\u2013886.","DOI":"10.1016\/j.jacc.2017.12.037"},{"key":"key-10.7555\/JBR.36.20220123-24","doi-asserted-by":"publisher","unstructured":"Gao R, Shi H, Chang S, et al.  The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction[J]. <i>Int Immunopharmacol, <\/i>2019, 74: 105575.","DOI":"10.1016\/j.intimp.2019.04.022"},{"key":"key-10.7555\/JBR.36.20220123-25","doi-asserted-by":"publisher","unstructured":"Li X, Bian Y, Pang P, et al.  Inhibition of Dectin-1 in mice ameliorates cardiac remodeling by suppressing NF-\u03baB\/NLRP3 signaling after myocardial infarction[J]. <i>Int Immunopharmacol, <\/i>2020, 80: 106116.","DOI":"10.1016\/j.intimp.2019.106116"},{"key":"key-10.7555\/JBR.36.20220123-26","doi-asserted-by":"publisher","unstructured":"Gao R, Li X, Xiang H, et al.  The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice[J]. <i>Int Immunopharmacol, <\/i>2021, 90: 107133.","DOI":"10.1016\/j.intimp.2020.107133"},{"key":"key-10.7555\/JBR.36.20220123-27","doi-asserted-by":"publisher","unstructured":"Wei Z, Fei Y, Wang Q, et al.  Loss of Camk2n1 aggravates cardiac remodeling and malignant ventricular arrhythmia after myocardial infarction in mice <i>via<\/i> NLRP3 inflammasome activation[J]. <i>Free Radic Biol Med, <\/i>2021, 167: 243\u2013257.","DOI":"10.1016\/j.freeradbiomed.2021.03.014"},{"key":"key-10.7555\/JBR.36.20220123-28","doi-asserted-by":"publisher","unstructured":"Aliaga J, Bonaventura A, Mezzaroma E, et al.  Preservation of contractile reserve and diastolic function by inhibiting the NLRP3 inflammasome with OLT1177<sup>\u00ae<\/sup> (Dapansutrile) in a mouse model of severe ischemic cardiomyopathy due to non-reperfused anterior wall myocardial infarction[J]. <i>Molecules, <\/i>2021, 26(12): 3534.","DOI":"10.3390\/molecules26123534"},{"key":"key-10.7555\/JBR.36.20220123-29","doi-asserted-by":"publisher","unstructured":"Zhang X, Zhao D, Feng J, et al.  LuQi Formula regulates NLRP3 inflammasome to relieve myocardial-infarction-induced cardiac remodeling in mice[J]. <i>Evid Based Complement Alternat Med, <\/i>2021, 2021: 5518083.","DOI":"10.1155\/2021\/5518083"},{"key":"key-10.7555\/JBR.36.20220123-30","doi-asserted-by":"publisher","unstructured":"Shen J, Fan Z, Sun G, et al.  Sacubitril\/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3-induced pyroptosis <i>via<\/i> the TAK1\/JNK signaling pathway[J]. <i>Mol Med Rep, <\/i>2021, 24(3): 676.","DOI":"10.3892\/mmr.2021.12315"},{"key":"key-10.7555\/JBR.36.20220123-31","doi-asserted-by":"publisher","unstructured":"Wei Q, Liu H, Liu M, et al.  Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure[J]. <i>Sci Rep, <\/i>2016, 6: 33677.","DOI":"10.1038\/srep33677"},{"key":"key-10.7555\/JBR.36.20220123-32","doi-asserted-by":"publisher","unstructured":"von Lueder TG, Wang BH, Kompa AR, et al.  Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy[J]. <i>Circ Heart Fail, <\/i>2015, 8(1): 71\u201378.","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785"},{"key":"key-10.7555\/JBR.36.20220123-33","doi-asserted-by":"publisher","unstructured":"Kim HS, No CW, Goo SH, et al.  An angiotensin receptor blocker prevents arrhythmogenic left atrial remodeling in a rat post myocardial infarction induced heart failure model[J]. <i>J Korean Med Sci, <\/i>2013, 28(5): 700\u2013708.","DOI":"10.3346\/jkms.2013.28.5.700"},{"key":"key-10.7555\/JBR.36.20220123-34","doi-asserted-by":"publisher","unstructured":"Nie C, Zou R, Pan S, et al.  Hydrogen gas inhalation ameliorates cardiac remodelling and fibrosis by regulating NLRP3 inflammasome in myocardial infarction rats[J]. <i>J Cell Mol Med, <\/i>2021, 25(18): 8997\u20139010.","DOI":"10.1111\/jcmm.16863"},{"key":"key-10.7555\/JBR.36.20220123-35","doi-asserted-by":"publisher","unstructured":"Luo B, Li B, Wang W, et al.  NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model[J]. <i>PLoS One, <\/i>2014, 9(8): e104771.","DOI":"10.1371\/journal.pone.0104771"},{"key":"key-10.7555\/JBR.36.20220123-36","doi-asserted-by":"publisher","unstructured":"Birnbaum Y, Tran D, Bajaj M, et al.  DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3\/ASC inflammasome[J]. <i>Basic Res Cardiol, <\/i>2019, 114(5): 35.","DOI":"10.1007\/s00395-019-0743-0"},{"key":"key-10.7555\/JBR.36.20220123-37","doi-asserted-by":"publisher","unstructured":"Chen H, Tran D, Yang HC, et al.  Dapagliflozin and ticagrelor have additive effects on the attenuation of the activation of the NLRP3 inflammasome and the progression of diabetic cardiomyopathy: an AMPK-mTOR interplay[J]. <i>Cardiovasc Drugs Ther, <\/i>2020, 34(4): 443\u2013461.","DOI":"10.1007\/s10557-020-06978-y"},{"key":"key-10.7555\/JBR.36.20220123-38","doi-asserted-by":"publisher","unstructured":"Wu X, Liu Y, Tu D, et al.  Role of NLRP3-inflammasome\/caspase-1\/galectin-3 pathway on atrial remodeling in diabetic rabbits[J]. <i>J Cardiovasc Trans Res, <\/i>2020, 13(5): 731\u2013740.","DOI":"10.1007\/s12265-020-09965-8"},{"key":"key-10.7555\/JBR.36.20220123-39","doi-asserted-by":"publisher","unstructured":"Elmadbouh I, Singla DK.  BMP-7 attenuates inflammation-induced pyroptosis and improves cardiac repair in diabetic cardiomyopathy[J]. <i>Cells, <\/i>2021, 10(10): 2640.","DOI":"10.3390\/cells10102640"},{"key":"key-10.7555\/JBR.36.20220123-40","doi-asserted-by":"publisher","unstructured":"Mao S, Chen P, Pan W, et al.  Exacerbated post-infarct pathological myocardial remodelling in diabetes is associated with impaired autophagy and aggravated NLRP3 inflammasome activation[J]. <i>ESC Heart Fail, <\/i>2022, 9(1): 303\u2013317.","DOI":"10.1002\/ehf2.13754"},{"key":"key-10.7555\/JBR.36.20220123-41","doi-asserted-by":"publisher","unstructured":"Kar S, Shahshahan HR, Hackfort BT, et al.  Exercise training promotes cardiac hydrogen sulfide biosynthesis and mitigates pyroptosis to prevent high-fat diet-induced diabetic cardiomyopathy[J]. <i>Antioxidants (Basel), <\/i>2019, 8(12): 638.","DOI":"10.3390\/antiox8120638"},{"key":"key-10.7555\/JBR.36.20220123-42","doi-asserted-by":"publisher","unstructured":"Logvinov SV, Naryzhnaya NV, Kurbatov BK, et al.  High carbohydrate high fat diet causes arterial hypertension and histological changes in the aortic wall in aged rats: the involvement of connective tissue growth factors and fibronectin[J]. <i>Exp Gerontol, <\/i>2021, 154: 111543.","DOI":"10.1016\/j.exger.2021.111543"},{"key":"key-10.7555\/JBR.36.20220123-43","doi-asserted-by":"publisher","unstructured":"Zhao P, Zhou W, Zhang Y, et al.  Aminooxyacetic acid attenuates post-infarct cardiac dysfunction by balancing macrophage polarization through modulating macrophage metabolism in mice[J]. <i>J Cell Mol Med, <\/i>2020, 24(4): 2593\u20132609.","DOI":"10.1111\/jcmm.14972"},{"key":"key-10.7555\/JBR.36.20220123-44","doi-asserted-by":"publisher","unstructured":"Sokolova M, Sjaastad I, Louwe MC, et al.  NLRP3 inflammasome promotes myocardial remodeling during diet-induced obesity[J]. <i>Front Immunol, <\/i>2019, 10: 1621.","DOI":"10.3389\/fimmu.2019.01621"},{"key":"key-10.7555\/JBR.36.20220123-45","doi-asserted-by":"publisher","unstructured":"Chen X, Li H, Wang K, et al.  Aerobic exercise ameliorates myocardial inflammation, fibrosis and apoptosis in high-fat-diet rats by inhibiting P2X7 purinergic receptors[J]. <i>Front Physiol, <\/i>2019, 10: 1286.","DOI":"10.3389\/fphys.2019.01286"},{"key":"key-10.7555\/JBR.36.20220123-46","doi-asserted-by":"publisher","unstructured":"Chen L, Yin Z, Qin X, et al.  CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis[J]. <i>Pharmacol Res, <\/i>2022, 176: 106086.","DOI":"10.1016\/j.phrs.2022.106086"},{"key":"key-10.7555\/JBR.36.20220123-47","doi-asserted-by":"publisher","unstructured":"Yang M, Zheng J, Miao Y, et al.  Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis[J]. <i>Arterioscler Thromb Vasc Biol, <\/i>2012, 32(7): 1675\u20131686.","DOI":"10.1161\/ATVBAHA.112.248732"},{"key":"key-10.7555\/JBR.36.20220123-48","doi-asserted-by":"publisher","unstructured":"Gan W, Ren J, Li T, et al.  The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation[J]. <i>Biochim Biophys Acta Mol Basis Dis, <\/i>2018, 1864(1): 1\u201310.","DOI":"10.1016\/j.bbadis.2017.10.001"},{"key":"key-10.7555\/JBR.36.20220123-49","doi-asserted-by":"publisher","unstructured":"Wang J, Deng B, Liu J, et al.  Xinyang Tablet inhibits MLK3-mediated pyroptosis to attenuate inflammation and cardiac dysfunction in pressure overload[J]. <i>J Ethnopharmacol, <\/i>2021, 274: 114078.","DOI":"10.1016\/j.jep.2021.114078"},{"key":"key-10.7555\/JBR.36.20220123-50","doi-asserted-by":"publisher","unstructured":"Ma S, Feng J, Lin X, et al.  Nicotinamide riboside alleviates cardiac dysfunction and remodeling in pressure overload cardiac hypertrophy[J]. <i>Oxid Med Cell Longev, <\/i>2021, 2021: 5546867.","DOI":"10.1155\/2021\/5546867"},{"key":"key-10.7555\/JBR.36.20220123-51","doi-asserted-by":"publisher","unstructured":"Zhao M, Zhang J, Xu Y, et al.  Selective inhibition of NLRP3 inflammasome reverses pressure overload-induced pathological cardiac remodeling by attenuating hypertrophy, fibrosis, and inflammation[J]. <i>Int Immunopharmacol, <\/i>2021, 99: 108046.","DOI":"10.1016\/j.intimp.2021.108046"},{"key":"key-10.7555\/JBR.36.20220123-52","doi-asserted-by":"publisher","unstructured":"Willeford A, Suetomi T, Nickle A, et al.  CaMKII\u03b4-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis[J]. <i>JCI Insight, <\/i>2018, 3(12): e97054.","DOI":"10.1172\/jci.insight.97054"},{"key":"key-10.7555\/JBR.36.20220123-53","doi-asserted-by":"publisher","unstructured":"Heijman J, Muna AP, Veleva T, et al.  Atrial myocyte NLRP3\/CaMKII nexus forms a substrate for postoperative atrial fibrillation[J]. <i>Circ Res, <\/i>2020, 127(8): 1036\u20131055.","DOI":"10.1161\/CIRCRESAHA.120.316710"},{"key":"key-10.7555\/JBR.36.20220123-54","doi-asserted-by":"publisher","unstructured":"Miller SA, Kolpakov MA, Guo X, et al.  Intracardiac administration of neutrophil protease cathepsin G activates noncanonical inflammasome pathway and promotes inflammation and pathological remodeling in non-injured heart[J]. <i>J Mol Cell Cardiol, <\/i>2019, 134: 29\u201339.","DOI":"10.1016\/j.yjmcc.2019.06.016"},{"key":"key-10.7555\/JBR.36.20220123-55","doi-asserted-by":"publisher","unstructured":"Li X, Zhu Q, Wang Q, et al.  Protection of sacubitril\/valsartan against pathological cardiac remodeling by inhibiting the NLRP3 inflammasome after relief of pressure overload in mice[J]. <i>Cardiovasc Drugs Ther, <\/i>2020, 34(5): 629\u2013640.","DOI":"10.1007\/s10557-020-06995-x"},{"key":"key-10.7555\/JBR.36.20220123-56","doi-asserted-by":"publisher","unstructured":"Wang J, Deng B, Liu Q, et al.  Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload[J]. <i>Cell Death Dis, <\/i>2020, 11(7): 574.","DOI":"10.1038\/s41419-020-02777-3"},{"key":"key-10.7555\/JBR.36.20220123-57","doi-asserted-by":"publisher","unstructured":"Zhou J, Tian G, Quan Y, et al.  Inhibition of P2X7 purinergic receptor ameliorates cardiac fibrosis by suppressing NLRP3\/IL-1<i>\u03b2<\/i> pathway[J]. <i>Oxid Med Cell Longev, <\/i>2020, 2020: 7956274.","DOI":"10.1155\/2020\/7956274"},{"key":"key-10.7555\/JBR.36.20220123-58","doi-asserted-by":"publisher","unstructured":"Lu B, Xie J, Fu D, et al.  Huoxue Qianyang Qutan recipe attenuates cardiac fibrosis by inhibiting the NLRP3 inflammasome signalling pathway in obese hypertensive rats[J]. <i>Pharm Biol, <\/i>2021, 59(1): 1043\u20131055.","DOI":"10.1080\/13880209.2021.1953541"},{"key":"key-10.7555\/JBR.36.20220123-59","doi-asserted-by":"publisher","unstructured":"Lv S, Zeng Z, Gan W, et al.  Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation[J]. <i>Acta Pharmacol Sin, <\/i>2021, 42(12): 2016\u20132032.","DOI":"10.1038\/s41401-021-00703-7"},{"key":"key-10.7555\/JBR.36.20220123-60","doi-asserted-by":"publisher","unstructured":"Li F, Zhang H, Yang L, et al.  NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling <i>via<\/i> increased TLR4 expression[J]. <i>J Mol Med (Berl), <\/i>2018, 96(11): 1189\u20131202.","DOI":"10.1007\/s00109-018-1691-0"},{"key":"key-10.7555\/JBR.36.20220123-61","doi-asserted-by":"publisher","unstructured":"Gao Y, Tong G, Zhang X, et al.  Interleukin-18 levels on admission are associated with mid-term adverse clinical events in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention[J]. <i>Int Heart J, <\/i>2010, 51(2): 75\u201381.","DOI":"10.1536\/ihj.51.75"},{"key":"key-10.7555\/JBR.36.20220123-62","doi-asserted-by":"publisher","unstructured":"El-Mesallamy HO, Hamdy NM, El-Etriby AK, et al.  Plasma granzyme B in ST elevation myocardial infarction versus non-ST elevation acute coronary syndrome: comparisons with IL-18 and fractalkine[J]. <i>Mediators Inflamm, <\/i>2013, 2013: 343268.","DOI":"10.1155\/2013\/343268"},{"key":"key-10.7555\/JBR.36.20220123-63","doi-asserted-by":"publisher","unstructured":"Hartford M, Wiklund O, Hult\u00e9n LM, et al.  Interleukin-18 as a predictor of future events in patients with acute coronary syndromes[J]. <i>Arterioscler Thromb Vasc Biol, <\/i>2010, 30(10): 2039\u20132046.","DOI":"10.1161\/ATVBAHA.109.202697"},{"key":"key-10.7555\/JBR.36.20220123-64","doi-asserted-by":"publisher","unstructured":"Ji Q, Zeng Q, Huang Y, et al.  Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome[J]. <i>Mediators Inflamm, <\/i>2014, 2014: 165742.","DOI":"10.1155\/2014\/165742"},{"key":"key-10.7555\/JBR.36.20220123-65","doi-asserted-by":"publisher","unstructured":"Xie S, Chen Y, Zhang H, et al.  Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction[J]. <i>Transl Res, <\/i>2015, 165(3): 387\u2013395.","DOI":"10.1016\/j.trsl.2014.09.001"},{"key":"key-10.7555\/JBR.36.20220123-66","doi-asserted-by":"publisher","unstructured":"\u00c5kerblom A, James SK, Lakic TG, et al.  Interleukin-18 in patients with acute coronary syndromes[J]. <i>Clin Cardiol, <\/i>2019, 42(12): 1202\u20131209.","DOI":"10.1002\/clc.23274"},{"key":"key-10.7555\/JBR.36.20220123-67","doi-asserted-by":"publisher","unstructured":"Wang X, Cai X, Chen L, et al.  The evaluation of plasma and leukocytic IL-37 expression in early inflammation in patients with acute ST-segment elevation myocardial infarction after PCI[J]. <i>Mediators Inflamm, <\/i>2015, 2015: 626934.","DOI":"10.1155\/2015\/626934"},{"key":"key-10.7555\/JBR.36.20220123-68","doi-asserted-by":"publisher","unstructured":"Pudil R, Pidrman V, Krejsek J, et al.  Cytokines and adhesion molecules in the course of acute myocardial infarction[J]. <i>Clin Chim Acta, <\/i>1999, 280(1\u20132): 127\u2013134.","DOI":"10.1016\/s0009-8981(98)00179-x"},{"key":"key-10.7555\/JBR.36.20220123-69","doi-asserted-by":"publisher","unstructured":"\u00d8rn S, Ueland T, Manhenke C, et al.  Increased interleukin-1\u03b2 levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention[J]. <i>J Intern Med, <\/i>2012, 272(3): 267\u2013276.","DOI":"10.1111\/j.1365-2796.2012.02517.x"},{"key":"key-10.7555\/JBR.36.20220123-70","doi-asserted-by":"publisher","unstructured":"Hermansson C, Lundqvist A, Wasslavik C, et al.  Reduced expression of <i>NLRP3<\/i> and <i>MEFV<\/i> in human ischemic heart tissue[J]. <i>Biochem Biophys Res Commun, <\/i>2013, 430(1): 425\u2013428.","DOI":"10.1016\/j.bbrc.2012.11.070"},{"key":"key-10.7555\/JBR.36.20220123-71","doi-asserted-by":"publisher","unstructured":"Raleigh JV, Mauro AG, Devarakonda T, et al.  Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia\/reperfusion injury <i>via<\/i> eNOS-dependent mechanism[J]. <i>Cardiovasc Res, <\/i>2017, 113(6): 609\u2013619.","DOI":"10.1093\/cvr\/cvw246"},{"key":"key-10.7555\/JBR.36.20220123-72","doi-asserted-by":"publisher","unstructured":"Lei Q, Yi T, Chen C.  NF-\u03baB-gasdermin D (GSDMD) axis couples oxidative stress and NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome-mediated cardiomyocyte pyroptosis following myocardial infarction[J]. <i>Med Sci Monit, <\/i>2018, 24: 6044\u20136052.","DOI":"10.12659\/MSM.908529"},{"key":"key-10.7555\/JBR.36.20220123-73","doi-asserted-by":"publisher","unstructured":"Yu Y, Jin L, Zhuang Y, et al.  Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats[J]. <i>Int J Mol Med, <\/i>2018, 41(6): 3509\u20133516.","DOI":"10.3892\/ijmm.2018.3572"},{"key":"key-10.7555\/JBR.36.20220123-74","doi-asserted-by":"publisher","unstructured":"Euler DE, Hughes PJ, Scanlon PJ.  Comparison of the effects of acute and chronic beta-blockade on infarct size in the dog after circumflex occlusion[J]. <i>Cardiovasc Drugs Ther, <\/i>1988, 2(2): 231\u2013238.","DOI":"10.1007\/BF00051239"},{"key":"key-10.7555\/JBR.36.20220123-75","doi-asserted-by":"publisher","unstructured":"Yu W, Jin G, Zhang J, et al.  Selective activation of cannabinoid receptor 2 attenuates myocardial infarction <i>via<\/i> suppressing NLRP3 inflammasome[J]. <i>Inflammation, <\/i>2019, 42(3): 904\u2013914.","DOI":"10.1007\/s10753-018-0945-x"},{"key":"key-10.7555\/JBR.36.20220123-76","unstructured":"Cui Q, Wang J, Liu X, et al.  Knockout of PTEN improves cardiac function and inhibits NLRP3-mediated cardiomyocyte pyroptosis in rats with myocardial ischemia-reperfusion[J]. <i>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (in Chinese), <\/i>2020, 36(3): 205\u2013211."},{"key":"key-10.7555\/JBR.36.20220123-77","doi-asserted-by":"publisher","unstructured":"Song MS, Salmena L, Pandolfi PP.  The functions and regulation of the PTEN tumour suppressor[J]. <i>Nat Rev Mol Cell Biol, <\/i>2012, 13(5): 283\u2013296.","DOI":"10.1038\/nrm3330"},{"key":"key-10.7555\/JBR.36.20220123-78","doi-asserted-by":"publisher","unstructured":"Han Y, Sun W, Ren D, et al.  SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion[J]. <i>Redox Biol, <\/i>2020, 34: 101538.","DOI":"10.1016\/j.redox.2020.101538"},{"key":"key-10.7555\/JBR.36.20220123-79","doi-asserted-by":"publisher","unstructured":"Yao L, Song J, Meng X, et al.  Periostin aggravates NLRP3 inflammasome-mediated pyroptosis in myocardial ischemia-reperfusion injury[J]. <i>Mol Cell Probes, <\/i>2020, 53: 101596.","DOI":"10.1016\/j.mcp.2020.101596"},{"key":"key-10.7555\/JBR.36.20220123-80","doi-asserted-by":"publisher","unstructured":"Climent M, Viggiani G, Chen Y, et al.  MicroRNA and ROS crosstalk in cardiac and pulmonary diseases[J]. <i>Int J Mol Sci, <\/i>2020, 21(12): 4370.","DOI":"10.3390\/ijms21124370"},{"key":"key-10.7555\/JBR.36.20220123-81","unstructured":"Lou Y, Wang S, Qu J, et al.  miR-424 promotes cardiac ischemia\/reperfusion injury by direct targeting of CRISPLD2 and regulating cardiomyocyte pyroptosis[J]. <i>Int J Clin Exp Pathol, <\/i>2018, 11(7): 3222\u20133235."},{"key":"key-10.7555\/JBR.36.20220123-82","doi-asserted-by":"publisher","unstructured":"Ding S, Liu D, Wang L, et al.  Inhibiting microRNA-29a protects myocardial ischemia-reperfusion injury by targeting SIRT1 and suppressing oxidative stress and NLRP3-mediated pyroptosis pathway[J]. <i>J Pharmacol Exp Ther, <\/i>2020, 372(1): 128\u2013135.","DOI":"10.1124\/jpet.119.256982"},{"key":"key-10.7555\/JBR.36.20220123-83","doi-asserted-by":"publisher","unstructured":"Lin J, Lin H, Ma C, et al.  MiR-149 aggravates pyroptosis in myocardial ischemia-reperfusion damage <i>via<\/i> silencing FoxO3[J]. <i>Med Sci Monit, <\/i>2019, 25: 8733\u20138743.","DOI":"10.12659\/MSM.918410"},{"key":"key-10.7555\/JBR.36.20220123-84","doi-asserted-by":"publisher","unstructured":"Zhou Y, Li K, Liu L, et al.  MicroRNA-132 promotes oxidative stress-induced pyroptosis by targeting sirtuin 1 in myocardial ischaemia-reperfusion injury[J]. <i>Int J Mol Med, <\/i>2020, 45(6): 1942\u20131950.","DOI":"10.3892\/ijmm.2020.4557"},{"key":"key-10.7555\/JBR.36.20220123-85","doi-asserted-by":"publisher","unstructured":"Dai Y, Wang S, Chang S, et al.  M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia\/reperfusion injury <i>via<\/i> inhibiting TXNIP and the TLR4\/NF-\u03baB\/NLRP3 inflammasome signaling pathway[J]. <i>J Mol Cell Cardiol, <\/i>2020, 142: 65\u201379.","DOI":"10.1016\/j.yjmcc.2020.02.007"},{"key":"key-10.7555\/JBR.36.20220123-86","doi-asserted-by":"publisher","unstructured":"Wei X, Peng H, Deng M, et al.  MiR-703 protects against hypoxia\/reoxygenation-induced cardiomyocyte injury <i>via<\/i> inhibiting the NLRP3\/caspase-1-mediated pyroptosis[J]. <i>J Bioenerg Biomembr, <\/i>2020, 52(3): 155\u2013164.","DOI":"10.1007\/s10863-020-09832-w"},{"key":"key-10.7555\/JBR.36.20220123-87","doi-asserted-by":"publisher","unstructured":"Yellon DM, Downey JM.  Preconditioning the myocardium: from cellular physiology to clinical cardiology[J]. <i>Physiol Rev, <\/i>2003, 83(4): 1113\u20131151.","DOI":"10.1152\/physrev.00009.2003"},{"key":"key-10.7555\/JBR.36.20220123-88","doi-asserted-by":"publisher","unstructured":"Heusch G.  Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning[J]. <i>Circ Res, <\/i>2015, 116(4): 674\u2013699.","DOI":"10.1161\/CIRCRESAHA.116.305348"},{"key":"key-10.7555\/JBR.36.20220123-89","doi-asserted-by":"publisher","unstructured":"Heusch G.  Myocardial ischaemia-reperfusion injury and cardioprotection in perspective[J]. <i>Nat Rev Cardiol, <\/i>2020, 17(12): 773\u2013789.","DOI":"10.1038\/s41569-020-0403-y"},{"key":"key-10.7555\/JBR.36.20220123-90","doi-asserted-by":"publisher","unstructured":"Gou X, Xu D, Li F, et al.  Pyroptosis in stroke-new insights into disease mechanisms and therapeutic strategies[J]. <i>J Physiol Biochem, <\/i>2021, 77(4): 511\u2013529.","DOI":"10.1007\/s13105-021-00817-w"},{"key":"key-10.7555\/JBR.36.20220123-91","doi-asserted-by":"publisher","unstructured":"Shi J, Tang M, Zhou S, et al.  Programmed cell death pathways in the pathogenesis of idiopathic inflammatory myopathies[J]. <i>Front Immunol, <\/i>2021, 12: 783616.","DOI":"10.3389\/fimmu.2021.783616"},{"key":"key-10.7555\/JBR.36.20220123-92","doi-asserted-by":"publisher","unstructured":"Woo Y, Lee HJ, Jung YM, et al.  Regulated necrotic cell death in alternative tumor therapeutic strategies[J]. <i>Cells, <\/i>2020, 9(12): 2709.","DOI":"10.3390\/cells9122709"},{"key":"key-10.7555\/JBR.36.20220123-93","doi-asserted-by":"publisher","unstructured":"Gong T, Liu L, Jiang W, et al.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases[J]. <i>Nat Rev Immunol, <\/i>2020, 20(2): 95\u2013112.","DOI":"10.1038\/s41577-019-0215-7"},{"key":"key-10.7555\/JBR.36.20220123-94","doi-asserted-by":"publisher","unstructured":"Zhang X, Qu H, Yang T, et al.  Regulation and functions of NLRP3 inflammasome in cardiac fibrosis: current knowledge and clinical significance[J]. <i>Biomed Pharmacother, <\/i>2021, 143: 112219.","DOI":"10.1016\/j.biopha.2021.112219"},{"key":"key-10.7555\/JBR.36.20220123-95","doi-asserted-by":"publisher","unstructured":"Song Z, Gong Q, Guo J.  Pyroptosis: mechanisms and links with fibrosis[J]. <i>Cells, <\/i>2021, 10(12): 3509.","DOI":"10.3390\/cells10123509"},{"key":"key-10.7555\/JBR.36.20220123-96","doi-asserted-by":"publisher","unstructured":"Wang C, Zhu L, Yuan W, et al.  Diabetes aggravates myocardial ischaemia reperfusion injury <i>via<\/i> activating Nox2-related programmed cell death in an AMPK-dependent manner[J]. <i>J Cell Mol Med, <\/i>2020, 24(12): 6670\u20136679.","DOI":"10.1111\/jcmm.15318"},{"key":"key-10.7555\/JBR.36.20220123-97","doi-asserted-by":"publisher","unstructured":"Wang X, Pan J, Liu H, et al.  AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model[J]. <i>Life Sci, <\/i>2019, 221: 249\u2013258.","DOI":"10.1016\/j.lfs.2019.02.035"},{"key":"key-10.7555\/JBR.36.20220123-98","doi-asserted-by":"publisher","unstructured":"Shen S, He F, Cheng C, et al.  Uric acid aggravates myocardial ischemia-reperfusion injury <i>via<\/i> ROS\/NLRP3 pyroptosis pathway[J]. <i>Biomed Pharmacother, <\/i>2021, 133: 110990.","DOI":"10.1016\/j.biopha.2020.110990"},{"key":"key-10.7555\/JBR.36.20220123-99","doi-asserted-by":"publisher","unstructured":"Wu A, Sun W, Mou F.  lncRNA-MALAT1 promotes high glucose-induced H9C2 cardiomyocyte pyroptosis by downregulating miR-141-3p expression[J]. <i>Mol Med Rep, <\/i>2021, 23(4): 259.","DOI":"10.3892\/mmr.2021.11898"},{"key":"key-10.7555\/JBR.36.20220123-100","doi-asserted-by":"publisher","unstructured":"Wang X, Lian Z, Ge Y, et al.  TRIM25 rescues against doxorubicin-Induced pyroptosis through promoting NLRP1 ubiquitination[J]. <i>Cardiovasc Toxicol, <\/i>2021, 21(10): 859\u2013868.","DOI":"10.1007\/s12012-021-09676-9"},{"key":"key-10.7555\/JBR.36.20220123-101","doi-asserted-by":"publisher","unstructured":"Li Y, Wang Y, Guo H, et al.  IRF2 contributes to myocardial infarction <i>via<\/i> regulation of GSDMD induced pyroptosis[J]. <i>Mol Med Rep, <\/i>2022, 25(2): 40.","DOI":"10.3892\/mmr.2021.12556"},{"key":"key-10.7555\/JBR.36.20220123-102","doi-asserted-by":"publisher","unstructured":"Yang F, Qin Y, Wang Y, et al.  Metformin inhibits the NLRP3 inflammasome <i>via<\/i> AMPK\/mTOR-dependent effects in diabetic cardiomyopathy[J]. <i>Int J Biol Sci, <\/i>2019, 15(5): 1010\u20131019.","DOI":"10.7150\/ijbs.29680"},{"key":"key-10.7555\/JBR.36.20220123-103","doi-asserted-by":"publisher","unstructured":"Liu J, Li Y, Yang M, et al.  SP1-induced ZFAS1 aggravates sepsis-induced cardiac dysfunction <i>via<\/i> miR-590-3p\/NLRP3-mediated autophagy and pyroptosis[J]. <i>Arch Biochem Biophys, <\/i>2020, 695: 108611.","DOI":"10.1016\/j.abb.2020.108611"},{"key":"key-10.7555\/JBR.36.20220123-104","doi-asserted-by":"publisher","unstructured":"Huang C, Andres AM, Ratliff EP, et al.  Preconditioning involves selective mitophagy mediated by parkin and p62\/SQSTM1[J]. <i>PLoS One, <\/i>2011, 6(6): e20975.","DOI":"10.1371\/journal.pone.0020975"},{"key":"key-10.7555\/JBR.36.20220123-105","doi-asserted-by":"publisher","unstructured":"Sun W, Lu H, Dong S, et al.  Beclin1 controls caspase-4 inflammsome activation and pyroptosis in mouse myocardial reperfusion-induced microvascular injury[J]. <i>Cell Commun Signal, <\/i>2021, 19(1): 107.","DOI":"10.1186\/s12964-021-00786-z"},{"key":"key-10.7555\/JBR.36.20220123-106","doi-asserted-by":"publisher","unstructured":"Wang Y, Jasper H, Toan S, et al.  Mitophagy coordinates the mitochondrial unfolded protein response to attenuate inflammation-mediated myocardial injury[J]. <i>Redox Biol, <\/i>2021, 45: 102049.","DOI":"10.1016\/j.redox.2021.102049"},{"key":"key-10.7555\/JBR.36.20220123-107","doi-asserted-by":"publisher","unstructured":"Chang X, Lochner A, Wang HH, et al.  Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control[J]. <i>Theranostics, <\/i>2021, 11(14): 6766\u20136785.","DOI":"10.7150\/thno.60143"},{"key":"key-10.7555\/JBR.36.20220123-108","doi-asserted-by":"publisher","unstructured":"Zhou H, Ren J, Toan S, et al.  Role of mitochondrial quality surveillance in myocardial infarction: from bench to bedside[J]. <i>Ageing Res Rev, <\/i>2021, 66: 101250.","DOI":"10.1016\/j.arr.2020.101250"},{"key":"key-10.7555\/JBR.36.20220123-109","doi-asserted-by":"publisher","unstructured":"Wang J, Zhou H.  Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury[J]. <i>Acta Pharm Sin B, <\/i>2020, 10(10): 1866\u20131879.","DOI":"10.1016\/j.apsb.2020.03.004"},{"key":"key-10.7555\/JBR.36.20220123-110","doi-asserted-by":"publisher","unstructured":"Qiu Y, Ma Y, Jiang M, et al.  Melatonin alleviates LPS-induced pyroptotic cell death in human stem cell-derived cardiomyocytes by activating autophagy[J]. <i>Stem Cells Int, <\/i>2021, 2021: 8120403.","DOI":"10.1155\/2021\/8120403"},{"key":"key-10.7555\/JBR.36.20220123-111","doi-asserted-by":"publisher","unstructured":"Guo R, Wang H, Cui N.  Autophagy regulation on pyroptosis: mechanism and medical implication in sepsis[J]. <i>Mediators Inflamm, <\/i>2021, 2021: 9925059.","DOI":"10.1155\/2021\/9925059"},{"key":"key-10.7555\/JBR.36.20220123-112","doi-asserted-by":"publisher","unstructured":"Chang P, Li H, Hu H, et al.  The role of HDAC6 in autophagy and NLRP3 inflammasome[J]. <i>Front Immunol, <\/i>2021, 12: 763831.","DOI":"10.3389\/fimmu.2021.763831"}],"container-title":["The Journal of Biomedical Research"],"original-title":[],"link":[{"URL":"http:\/\/www.jbr-pub.org.cn\/fileSWYXYJZZYWB\/journal\/article\/swyxyjzzywb\/2022\/6\/JBR-2022-0123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T12:13:05Z","timestamp":1678363985000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.36.20220123?viewType=HTML"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":112,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"alternative-id":["JBR-2022-0123"],"URL":"https:\/\/doi.org\/10.7555\/jbr.36.20220123","relation":{},"ISSN":["1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}